Saskatchewan announced a pharmacy pilot in September 2024 to expand access to assessment and treatment for strep throat and middle-ear infections. Ten pharmacies were to offer both services, while another 50 sites would assess ear infections, following training and regulatory preparation.
The pilot expanded pharmacists’ role
Participating pharmacists could assess eligible patients and prescribe and dispense treatment when indicated. For suspected strep throat, selected sites would use rapid point-of-care testing rather than rely on symptoms alone.
The announcement did not mean every pharmacy could immediately provide both services.
Access was the central goal
People with sore throats or ear pain often seek primary care for conditions that can be evaluated using structured criteria. Community pharmacies have long opening hours and are widely distributed.
Convenience can reduce pressure on clinics only if assessment remains clinically sound.
Sore throat has several causes
Viruses cause many sore throats and do not improve with antibiotics. Group A streptococcus can require testing and treatment, while breathing difficulty, dehydration or severe systemic illness needs urgent medical attention.
A negative or unsuitable test must not be replaced by guesswork.
Ear complaints require careful examination
Pain may arise from middle-ear infection, outer-ear inflammation, wax, injury or referred pain. Age, symptom duration and examination findings help determine whether observation, medication or medical referral is appropriate.
Very young children and complicated cases may fall outside a pharmacist’s pathway.
Antibiotic stewardship remained essential
Unnecessary antibiotics cause side effects and contribute to resistance. Protocols should specify when testing, delayed treatment or no antibiotic is appropriate and should record allergies and recent medicines.
Patients need clear advice on expected recovery and warning signs.
Training and equipment needed validation
The province said participating pharmacists would receive additional preparation. Competency includes collecting samples, examining ears, interpreting results, recognizing emergencies and documenting care.
Quality controls for devices and infection prevention are as important as prescribing authority.
Information should follow the patient
Assessment results and medicines should be available to other authorized providers through provincial records where permitted. Communication prevents duplicate tests, conflicting prescriptions and missed follow-up.
Privacy protections still apply when information moves between a pharmacy and clinic.
A pilot should answer measurable questions
Evaluation could track wait times, appropriate antibiotic use, referrals, repeat visits, adverse events and patient experience. Comparing participating and non-participating communities would help separate the program’s effect from seasonal infection changes.
Volume alone would not prove better care.
Expansion should follow evidence
The initiative offered a practical route to quicker assessment while preserving a referral role for physicians and nurse practitioners. Public messages needed to identify participating locations and eligibility accurately.
If results showed safe decisions and meaningful access gains, Saskatchewan could expand responsibly. If problems emerged, protocols, training and scope should change before scale increased. The useful outcome was integrated care, not moving patients between disconnected queues.
Pharmacists also needed enough time and private space for assessment. A rushed retail interaction would not meet the program’s clinical promise. Funding should reward appropriate evaluation and referral, not antibiotic volume. Clear public information about fees, coverage and appointments would prevent surprises and help patients choose the right entry point.
